<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - [REDACTED]</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">REASON FOR VISIT</a></li><li><a href="#id3">Medications</a></li><li><a href="#id4">Social History</a></li><li><a href="#id5">Vital Signs</a></li><li><a href="#id6">Encounters</a></li><li><a href="#id7">Assessments</a></li><li><a href="#id8">Plan Of Treatment</a></li><li><a href="#id9">Progress Notes</a></li><li><a href="#id10">History and Physical Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><table width="100%" border="1"><thead><tr><th>Allergen (clinical drug ingredient)</th><th>Drug/Non Drug Allergy documented on EMR</th><th>Reaction</th><th>Allergy Type</th><th>Onset Date</th><th>Status</th></tr></thead><tbody><tr><td ID="allergy1">Substance with penicillin structure and antibacterial mechanism of action (substance)</td><td>Penicillins</td><td ID="reaction1">Unknown</td><td>Drug Allergy</td><td/><td>Active</td></tr><tr><td ID="allergy2">Substance with sulfonamide structure and antibacterial mechanism of action (substance)</td><td>Sulfa Antibiotics</td><td ID="reaction2">Unknown</td><td>Drug Allergy</td><td/><td>Active</td></tr></tbody></table></div><h3><a name="id2" href="#toc">REASON FOR VISIT</a></h3><div>3 month f/u</div><h3><a name="id3" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Flomax 0.4 MG</td><td ID="instruction1">1 capsule Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication2">Singulair 10 MG</td><td ID="instruction2">1 tablet Orally Once a day</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication3">Lisinopril 20 MG</td><td ID="instruction3">1 tablet Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication4">ZyrTEC 10 mg</td><td ID="instruction4">1 tab oral Once a day</td><td ID="medication4notes">*Pick strength-form from Medispan for eRX*</td><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication5">Flonase 50 MCG/ACT</td><td ID="instruction5">1 spray in each nostril Nasally Once a day</td><td ID="medication5notes">*Reorder from Medispan for eRx and Interaction Alerts*</td><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication6">Lipitor 40 MG</td><td ID="instruction6">1 tablet Orally Once a day</td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Social History</a></h3><div><span class="content_span">Sex Assigned At Birth:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th></tr></thead><tbody><tr><td ID="BirthSexInfo">Sex Assigned At Birth</td><td>Male</td></tr></tbody></table></div><h3><a name="id5" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Height</th><td>67 in</td><td>[REDACTED]</td></tr><tr><th ID="vital2">Weight</th><td>139 lbs</td><td>[REDACTED]</td></tr><tr><th ID="vital3">Weight-kg</th><td>63.05 kg</td><td>[REDACTED]</td></tr><tr><th ID="vital4">BMI</th><td>21.77 kg/m2</td><td>[REDACTED]</td></tr><tr><th ID="vital5">Blood pressure systolic</th><td>112 mm Hg</td><td>[REDACTED]</td></tr><tr><th ID="vital6">Blood pressure diastolic</th><td>76 mm Hg</td><td>[REDACTED]</td></tr><tr><th ID="vital7">Heart Rate</th><td>109 /min</td><td>[REDACTED]</td></tr><tr><th ID="vital8">Temperature</th><td>97.9 degrees Fahrenheit</td><td>[REDACTED]</td></tr></tbody></table></div><h3><a name="id6" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>MCM [REDACTED] Hwy</td><td>[REDACTED][REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>HTN (HYPERTENSION) I10 ; HLD (HYPERLIPIDEMIA) E78.5 ; PROSTATE CARCINOMA C61 ; Seasonal allergic rhinitis, unspecified trigger J30.2 and Spinal stenosis, sacral and sacrococcygeal region M48.08</td></tr></tbody></table></div><h3><a name="id7" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th><th>Section Notes</th></tr></thead><tbody><tr><td ID="ref1">[REDACTED]</td><td>HTN (HYPERTENSION) (ICD-10 - I10)</td><td/><td>Patient doing very well with present medication continue present medication at established dose</td><td/><td/></tr><tr><td ID="ref2">[REDACTED]</td><td>HLD (HYPERLIPIDEMIA) (ICD-10 - E78.5)</td><td/><td>Pending the results of the patient's lipid profile continue present medication at established dose</td><td/><td/></tr><tr><td ID="ref3">[REDACTED]</td><td>PROSTATE CARCINOMA (ICD-10 - C61)</td><td/><td>Patient continues to follow-up with [REDACTED] and his oncologist</td><td/><td/></tr><tr><td ID="ref4">[REDACTED]</td><td>Seasonal allergic rhinitis, unspecified trigger (ICD-10 - J30.2)</td><td/><td>Patient reports good symptom control we will continue present medication at established dose</td><td/><td/></tr><tr><td ID="ref5">[REDACTED]</td><td>Spinal stenosis, sacral and sacrococcygeal region (ICD-10 - M48.08)</td><td/><td>Patient doing well activities not much limited at this point</td><td/><td/></tr></tbody></table></div><h3><a name="id8" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Medication</span><table width="100%" border="1"><thead><tr><th>Medication Name</th><th>Sig</th><th>Start Date</th><th>Stop Date</th><th>Notes</th></tr></thead><tbody><tr><td ID="potMeds1">Flomax 0.4 MG</td><td>1 capsule Orally Once a day</td><td/><td/><td/></tr><tr><td ID="potMeds2">Singulair 10 MG</td><td>1 tablet Orally Once a day</td><td>[REDACTED]</td><td/><td/></tr><tr><td ID="potMeds3">Lisinopril 20 MG</td><td>1 tablet Orally Once a day</td><td/><td/><td/></tr><tr><td ID="potMeds4">ZyrTEC 10 mg</td><td>1 tab oral Once a day</td><td>[REDACTED]</td><td/><td>*Pick strength-form from Medispan for eRX*</td></tr><tr><td ID="potMeds5">Flonase 50 MCG/ACT</td><td>1 spray in each nostril Nasally Once a day</td><td>[REDACTED]</td><td/><td>*Reorder from Medispan for eRx and Interaction Alerts*</td></tr><tr><td ID="potMeds6">Lipitor 40 MG</td><td>1 tablet Orally Once a day</td><td/><td/><td/></tr></tbody></table><span class="content_span">Treatment Notes</span><table width="100%" border="1"><thead><tr><th>Assessment</th><th>Notes</th></tr></thead><tbody><tr><td ID="instructionpot1">HTN (HYPERTENSION)</td><td>Patient doing very well with present medication continue present medication at established dose</td></tr><tr><td ID="instructionpot2">HLD (HYPERLIPIDEMIA)</td><td>Pending the results of the patient's lipid profile continue present medication at established dose</td></tr><tr><td ID="instructionpot3">PROSTATE CARCINOMA</td><td>Patient continues to follow-up with [REDACTED] and his oncologist</td></tr><tr><td ID="instructionpot4">Seasonal allergic rhinitis, unspecified trigger</td><td>Patient reports good symptom control we will continue present medication at established dose</td></tr><tr><td ID="instructionpot5">Spinal stenosis, sacral and sacrococcygeal region</td><td>Patient doing well activities not much limited at this point</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="nextAppt">Follow Up: 6 Months, Reason: </td></tr><tr><td ID="futureAppt1">Provider Name:[REDACTED], [REDACTED] 08:15:00 AM, [REDACTED][REDACTED][REDACTED]-4416, [REDACTED]</td></tr></tbody></table></div><h3><a name="id9" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>[REDACTED] <span class="bold">DOB:</span> [REDACTED] ([REDACTED] M) <span class="bold">Acc No.</span> 472152 <span class="bold">DOS:</span> [REDACTED]</content></td></tr></thead><tbody><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold"/></td></tr><tr><td align="left"><span class="bold">Patient:Â </span>[REDACTED]<br/><span class="bold">Account Number: </span>472152</td><td align="right"><span class="bold">Provider:Â </span>[REDACTED]</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>[REDACTED]<span class="bold">Â Â Â Age: </span>70 Y<span class="bold">Â Â Â Sex: </span>Male</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td><span class="bold">Phone: </span>[REDACTED]</td></tr><tr><td colspan="2"><span class="bold">Address: </span>[REDACTED][REDACTED][REDACTED]</td></tr><tr><td colspan="2"><span class="bold">Pcp: </span>[REDACTED]</td></tr></tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>Â Â Â 3 month f/u</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">HPI: </span><br/>Â Â Â <span class="Underline">AWV-COA-HEDIS</span>:Â <br/>Â Â Â Â Â Â  Patient presents [REDACTED] for follow-up medication review.Â  He has no complaints [REDACTED].  He is doing very well with his treatment for prostate cancer.Â  He is following up with [REDACTED] his only complaint is that he had does not have much of an appetite.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span>Â </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Surgical History:</span>Â </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Hospitalization/Major Diagnostic Procedure:</span>Â </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span>Â TakingLisinopril 20 MG Tablet 1 tablet Orally Once a day Lipitor 40 MG Tablet 1 tablet Orally Once a day ZyrTEC 10 mg tablet 1 tab oral Once a day , Notes to Pharmacist: *Pick strength-form from Medispan for eRX*Flonase 50 MCG/ACT Suspension 1 spray in each nostril Nasally Once a day , Notes to Pharmacist: *Reorder from Medispan for eRx and Interaction Alerts*Singulair 10 MG Tablet 1 tablet Orally Once a day Flomax 0.4 MG Capsule 1 capsule Orally Once a day Medication List reviewed and reconciled with the patientTaking Lisinopril 20 MG Tablet 1 tablet Orally Once a day Taking Lipitor 40 MG Tablet 1 tablet Orally Once a day Taking ZyrTEC 10 mg tablet 1 tab oral Once a day , Notes to Pharmacist: *Pick strength-form from Medispan for eRX*Taking Flonase 50 MCG/ACT Suspension 1 spray in each nostril Nasally Once a day , Notes to Pharmacist: *Reorder from Medispan for eRx and Interaction Alerts*Taking Singulair 10 MG Tablet 1 tablet Orally Once a day Taking Flomax 0.4 MG Capsule 1 capsule Orally Once a day Medication List reviewed and reconciled with the patient</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Allergies:</span>Â PenicillinsSulfa Antibioticsno[Allergies Verified]</td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Vitals:</span>Â Ht: 67 in, Wt: <span class="bold">139</span> lbs, Wt-kg: 63.05 kg, BMI: <span class="bold">21.77</span> Index, BP: <span class="bold">112/76</span> mm Hg, HR: <span class="bold">109</span> /min, Temp: <span class="bold">97.9</span> F, Body Surface Area: 1.72.<br/></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content class="bold">Examination: <br/></content>Â Â Â <span class="Underline">General Examination:</span><br/>Â Â Â Â Â Â General appearance:Â alert, well-nourished and in no acute distress.Â <br/>Â Â Â Â Â Â Neck / thyroid:Â neck is supple, with full range of motion and no cervical lymphadenopathy.Â <br/>Â Â Â Â Â Â Heart:Â regular rate and rhythm without murmurs, gallops, clicks or rubs, no jugular venous distention.Â <br/>Â Â Â Â Â Â Lungs:Â clear to auscultation bilaterally, with good air movement and no rales, rhonchi or wheezes.Â Â Â Â <br/></td></tr><tr><td/></tr></tbody></table></li></ul><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1.Â HTN (HYPERTENSION) - I10 (Primary)Â 2.Â HLD (HYPERLIPIDEMIA) - E78.5Â 3.Â PROSTATE CARCINOMA - C61Â 4.Â Seasonal allergic rhinitis, unspecified trigger - J30.2Â 5.Â Spinal stenosis, sacral and sacrococcygeal region - M48.08Â </td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1.Â HTN (HYPERTENSION)</span>Â <br/>Continue Lisinopril Tablet, 20 MG, 1 tablet, Orally, Once a day.Â Â <br/>Notes: Patient doing very well with present medication continue present medication at established doseÂ Â </td></tr><tr><td/></tr><tr><td><span class="bold">2.Â HLD (HYPERLIPIDEMIA)</span>Â <br/>Continue Lipitor Tablet, 40 MG, 1 tablet, Orally, Once a day.Â Â <br/>Notes: Pending the results of the patient's lipid profile continue present medication at established doseÂ Â </td></tr><tr><td/></tr><tr><td><span class="bold">3.Â PROSTATE CARCINOMA</span>Â <br/>Continue Flomax Capsule, 0.4 MG, 1 capsule, Orally, Once a day.Â Â <br/>Notes: Patient continues to follow-up with [REDACTED] and his oncologistÂ Â </td></tr><tr><td/></tr><tr><td><span class="bold">4.Â Seasonal allergic rhinitis, unspecified trigger</span>Â <br/>Continue ZyrTEC tablet, 10 mg, 1 tab, oral, Once a day, Notes to Pharmacist: *Pick strength-form from Medispan for eRX*;Â Continue Flonase Suspension, 50 MCG/ACT, 1 spray in each nostril, Nasally, Once a day, Notes to Pharmacist: *Reorder from Medispan for eRx and Interaction Alerts*;Â Continue Singulair Tablet, 10 MG, 1 tablet, Orally, Once a day.Â Â <br/>Notes: Patient reports good symptom control we will continue present medication at established doseÂ Â </td></tr><tr><td/></tr><tr><td><span class="bold">5.Â Spinal stenosis, sacral and sacrococcygeal region</span>Â <br/>Notes: Patient doing well activities not much limited at this pointÂ Â </td></tr><tr><td/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Procedure Codes:</span>Â </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Preventive Medicine:</span>Â <br/>Â Â Preventative Medicine:Â <br/>Â Â Â Â Â Â Â Colorectal ScreeningÂ 2021 Colonoscopy ([REDACTED] as a part of workup for prostate cancer).Â </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Follow Up:</span>Â 6 Months</td></tr></tbody></table></li></ul><ul><li/></ul><br/><content><span class="bold">Billing  Information:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Visit Code:</span></content>Â <br/>99213 Office Visit, Est Pt., Level 3.  </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Procedure Codes:</span></content>Â </td></tr></tbody></table></li></ul><br/><tr><td valign="top"><span class="bold">Care Plan Details</span><ul><li><table cellpadding="1" cellspacing="0" border="1"><tbody/></table></li></ul></td></tr><ul><li><table width="100%" border="0"><tbody><tr><td/></tr><tr><td valign="top"/></tr><tr><td/></tr><tr><td/></tr><tr><td valign="top">Electronically signed by [REDACTED] , MD, H0651  on [REDACTED] 10:23 AM CDT</td></tr><tr><td valign="top">Sign off status: Completed</td></tr><tr><td/></tr></tbody></table></li></ul><span class="content_span">true</span></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"><span class="bold">Provider:</span>Â [REDACTED]</td><td align="right"><span class="bold">Date:Â </span>[REDACTED]</td></tr><tr><td/><td align="right"><span class="content_span">Generated for Printing/Faxing/eTransmitting on:Â [REDACTED] 12:51 PM CDT</span></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><h3><a name="id10" href="#toc">History and Physical Notes</a></h3><div><ul><li><p>HPI (History of Present Illness)</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th><th>Category Notes</th></tr></thead><tbody><tr><td>AWV-COA-HEDIS</td><td/><td colspan="2"/><td>Patient presents [REDACTED] for follow-up medication review.  He has no complaints [REDACTED].  He is doing very well with his treatment for prostate cancer.  He is following up with [REDACTED] his only complaint is that he had does not have much of an appetite</td></tr></tbody></table><br/><p>Examination</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th><th>Category Notes</th></tr></thead><tbody><tr><td rowspan="4">General Examination</td><td>General appearance:</td><td colspan="2">alert, well-nourished and in no acute distress</td><td rowspan="4"/></tr><tr><td>Neck / thyroid:</td><td colspan="2">neck is supple, with full range of motion and no cervical lymphadenopathy</td></tr><tr><td>Heart:</td><td colspan="2">regular rate and rhythm without murmurs, gallops, clicks or rubs, no jugular venous distention</td></tr><tr><td>Lungs:</td><td colspan="2">clear to auscultation bilaterally, with good air movement and no rales, rhonchi or wheezes</td></tr></tbody></table><br/></li></ul></div><br/><br/>
</body></html>